Basic Information
| RNALocate ID: | RLID-D:11001580 |
| RNA Symbol: | hsa-miR-33b-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-33b-3p |
| RNA ID: | miRBase:MIMAT0004811 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID-D:11000705 | Microvesicle | Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-33b-3p | Medulloblastoma | MNDR-E-MI-41737 |
| MNDR | hsa-miR-33b-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-41738 |
| MNDR | hsa-miR-33b-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-41739 |
| MNDR | hsa-miR-33b-3p | Lymphoma | MNDR-E-MI-41740 |
| MNDR | hsa-miR-33b-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-41741 |
| MNDR | hsa-miR-33b-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-41742 |
| MNDR | hsa-miR-33b-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-41743 |
| MNDR | hsa-miR-33b-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-41744 |
| MNDR | hsa-miR-33b-3p | Her2-receptor positive breast cancer | MNDR-E-MI-41745 |
| MNDR | hsa-miR-33b-3p | Prostate cancer | MNDR-E-MI-41746 |
| MNDR | hsa-miR-33b-3p | Gastric cancer | MNDR-E-MI-41747 |
| MNDR | hsa-miR-33b-3p | Leukemia | MNDR-E-MI-41748 |
| MNDR | hsa-miR-33b-3p | Parkinson disease | MNDR-E-MI-41749 |
| MNDR | hsa-miR-33b-3p | Breast cancer | MNDR-E-MI-41750 |
| MNDR | hsa-miR-33b-3p | Pancreatic cancer | MNDR-E-MI-41751 |
| MNDR | hsa-miR-33b-3p | Melanoma | MNDR-E-MI-41752 |
| MNDR | hsa-miR-33b-3p | Nephroblastoma | MNDR-E-MI-41753 |
| MNDR | hsa-miR-33b-3p | Familial ovarian cancer | MNDR-E-MI-41754 |
| MNDR | hsa-miR-33b-3p | Carcinoma ductal breast | MNDR-E-MI-41755 |
| MNDR | hsa-miR-33b-3p | Malignant glioma | MNDR-E-MI-41756 |
| MNDR | hsa-miR-33b-3p | Osteosarcoma | MNDR-E-MI-41757 |
| MNDR | hsa-miR-33b-3p | Breast carcinoma | MNDR-E-MI-41758 |
| MNDR | hsa-miR-33b-3p | Liver cancer | MNDR-E-MI-41759 |
| MNDR | hsa-miR-33b-3p | Lung adenocarcinoma | MNDR-E-MI-41760 |
| MNDR | hsa-miR-33b-3p | Ovarian carcinoma | MNDR-E-MI-41761 |
| MNDR | hsa-miR-33b-3p | Pancreatic adenocarcinoma | MNDR-E-MI-41762 |
| MNDR | hsa-miR-33b-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-41763 |
| MNDR | hsa-miR-33b-3p | Cholangiocarcinoma | MNDR-E-MI-41764 |
| MNDR | hsa-miR-33b-3p | Lung small cell carcinoma | MNDR-E-MI-41765 |
| MNDR | hsa-miR-33b-3p | Breast invasive carcinoma | MNDR-E-MI-41766 |
| MNDR | hsa-miR-33b-3p | Hepatocellular carcinoma | MNDR-E-MI-41767 |
| MNDR | hsa-miR-33b-3p | Embryonal cancer | MNDR-E-MI-41768 |
| MNDR | hsa-miR-33b-3p | Familiar ovarian carcinoma | MNDR-E-MI-41769 |
| MNDR | hsa-miR-33b-3p | B-cell lymphoma | MNDR-E-MI-41770 |
| MNDR | hsa-miR-33b-3p | Nasopharynx carcinoma | MNDR-E-MI-41771 |
| MNDR | hsa-miR-33b-3p | Nasopharyngeal cancer | MNDR-E-MI-41772 |
| MNDR | hsa-miR-33b-3p | Breast cancer her3+ negative | MNDR-E-MI-41773 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | HMGA2 | Homo sapiens | RR00713571 |
TOP